文献速递妇产影像US

胎儿医学基金会竞争风险模型在孕早期晚期预测小于胎龄儿的验证

Validation of Fetal Medicine Foundation competing-risks model for small-for-gestational-age neonate in early third trimester.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

本研究为回顾性多中心队列,纳入3012例单胎妊娠妇女,在孕30+0至34+0周行超声检查,验证胎儿医学基金会36周竞争风险模型预测小于胎龄儿(SGA)的效能。模型结合母体因素、估计胎儿体重(EFW)和子宫动脉搏动指数(UtA-PI),预测SGA<第3百分位和<第10百分位,区分度与校准度良好,尤其对<37周分娩的SGA预测效果更佳。

要点

  • 孕30+0至34+0周应用FMF 36周竞争风险模型可有效预测SGA,尤其对<37周分娩者。
  • 预测SGA<第3百分位时,假阳性率10%下,<37周分娩的检出率为88.0%。
  • 若以EFW和UtA-PI为标志物、目标检出90%的SGA<第10百分位,需在初评后2周内筛查10.8%人群。

核心结论

  • 36周FMF竞争风险模型在孕30+0至34+0周同样适用且准确,能有效进行风险分层,尤其对<37周分娩的SGA病例。

研究设计与样本

  • 回顾性多中心队列研究,数据来自前瞻性收集的3012例单胎妊娠妇女,在孕30+0至34+0周行超声检查,作为普遍筛查项目的一部分。

诊断标准与关键数值

  • 模型默认纳入母体因素(年龄、产科和病史、体重、身高、吸烟状态、种族、受孕方式)、EFW和UtA-PI,计算不同出生体重百分位和分娩孕周切点的风险。
  • 假阳性率10%时,母体因素、EFW和UtA-PI预测<37周、<40周和<42周分娩的SGA<第3百分位的检出率分别为88.0%、74.4%和72.8%。
  • 假阳性率10%时,上述模型预测<37周、<40周和<42周分娩的SGA<第10百分位的检出率分别为86.1%、69.3%和66.2%。
  • 以EFW和UtA-PI为标志物、目标检出90%的SGA<第10百分位时,初评后2周内应筛查10.8%人群,2-4周内额外筛查7.2%(总筛查阳性率18.0%),4-6周内额外筛查11.7%(总筛查阳性率29.7%)。
  • 新模型校准良好。

临床应用与阅片要点

  • 孕30+0至34+0周可应用FMF 36周竞争风险模型进行SGA风险分层,尤其关注<37周分娩的高危病例。
  • 模型预测SGA<第3百分位时,加入UtA-PI可提高检出率,且检查至分娩间隔越短预测越好。
  • 根据目标检出率(如90%的SGA<第10百分位)可参考模型给出的筛查阳性率安排后续超声随访间隔。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the new 36-week Fetal Medicine Foundation (FMF) competing-risks model for the prediction of small-for-gestational age (SGA) at an earlier gestation of 30 + 0 to 34 + 0 weeks.

METHODS: This was a retrospective multicenter cohort study of prospectively collected data on 3012 women with a singleton pregnancy undergoing ultrasound examination at 30 + 0 to 34 + 0 weeks' gestation as part of a universal screening program. We used the default FMF competing-risks model for prediction of SGA at 36 weeks' gestation combining maternal factors (age, obstetric and medical history, weight, height, smoking status, race, mode of conception), estimated fetal weight (EFW) and uterine artery pulsatility index (UtA-PI) to calculate risks for different cut-offs of birth-weight percentile and gestational age at delivery. We examined the accuracy of the model by means of discrimination and calibration.

RESULTS: The prediction of SGA < 3rd percentile improved with the addition of UtA-PI and with a shorter examination-to-delivery interval. For a 10% false-positive rate, maternal factors, EFW and UtA-PI predicted 88.0%, 74.4% and 72.8% of SGA < 3rd percentile delivered at < 37, < 40 and < 42 weeks' gestation, respectively. The respective values for SGA < 10th percentile were 86.1%, 69.3% and 66.2%. In terms of population stratification, if the biomarkers used are EFW and UtA-PI and the aim is to detect 90% of SGA < 10th percentile, then 10.8% of the population should be scanned within 2 weeks after the initial assessment, an additional 7.2% (total screen-positive rate (SPR), 18.0%) should be scanned within 2-4 weeks after the initial assessment and an additional 11.7% (total SPR, 29.7%) should be examined within 4-6 weeks after the initial assessment. The new model was well calibrated.

CONCLUSIONS: The 36-week FMF competing-risks model for SGA is also applicable and accurate at 30 + 0 to 34 + 0 weeks and provides effective risk stratification, especially for cases leading to delivery < 37 weeks of gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dagklis T, Papastefanou I, Tsakiridis I, et al. Validation of Fetal Medicine Foundation competing-risks model for small-for-gestational-age neonate in early third trimester. Ultrasound Obstet Gynecol. 2024. PMID: 37743681. doi:10.1002/uog.27498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。